Gupta Amit, Rajamohan Naveen, Bansal Bhavik, Chaudhri Sukriti, Chandarana Hersh, Bagga Barun
All India Institute of Medical Sciences, New Delhi, India.
The University of Texas Southwestern Medical Center, Dallas, United States.
Abdom Radiol (NY). 2025 May 26. doi: 10.1007/s00261-025-04990-0.
The rapid advancements in artificial intelligence (AI) carry the promise to reshape abdominal imaging by offering transformative solutions to challenges in disease detection, classification, and personalized care. AI applications, particularly those leveraging deep learning and radiomics, have demonstrated remarkable accuracy in detecting a wide range of abdominal conditions, including but not limited to diffuse liver parenchymal disease, focal liver lesions, pancreatic ductal adenocarcinoma (PDAC), renal tumors, and bowel pathologies. These models excel in the automation of tasks such as segmentation, classification, and prognostication across modalities like ultrasound, CT, and MRI, often surpassing traditional diagnostic methods. Despite these advancements, widespread adoption remains limited by challenges such as data heterogeneity, lack of multicenter validation, reliance on retrospective single-center studies, and the "black box" nature of many AI models, which hinder interpretability and clinician trust. The absence of standardized imaging protocols and reference gold standards further complicates integration into clinical workflows. To address these barriers, future directions emphasize collaborative multi-center efforts to generate diverse, standardized datasets, integration of explainable AI frameworks to existing picture archiving and communication systems, and the development of automated, end-to-end pipelines capable of processing multi-source data. Targeted clinical applications, such as early detection of PDAC, improved segmentation of renal tumors, and improved risk stratification in liver diseases, show potential to refine diagnostic accuracy and therapeutic planning. Ethical considerations, such as data privacy, regulatory compliance, and interdisciplinary collaboration, are essential for successful translation into clinical practice. AI's transformative potential in abdominal imaging lies not only in complementing radiologists but also in fostering precision medicine by enabling faster, more accurate, and patient-centered care. Overcoming current limitations through innovation and collaboration will be pivotal in realizing AI's full potential to improve patient outcomes and redefine the landscape of abdominal radiology.
人工智能(AI)的快速发展有望通过为疾病检测、分类和个性化医疗中的挑战提供变革性解决方案,重塑腹部影像学。人工智能应用,特别是那些利用深度学习和放射组学的应用,在检测多种腹部疾病方面已展现出卓越的准确性,包括但不限于弥漫性肝实质疾病、肝脏局灶性病变、胰腺导管腺癌(PDAC)、肾肿瘤和肠道病变。这些模型在超声、CT和MRI等多种模态的分割、分类和预后等任务的自动化方面表现出色,常常超越传统诊断方法。尽管有这些进展,但广泛应用仍受到诸多挑战的限制,如数据异质性、缺乏多中心验证、依赖回顾性单中心研究以及许多人工智能模型的“黑箱”性质,这些都阻碍了可解释性和临床医生的信任。缺乏标准化的成像协议和参考金标准进一步使整合到临床工作流程变得复杂。为解决这些障碍,未来的方向强调多中心合作努力,以生成多样化、标准化的数据集,将可解释人工智能框架集成到现有的图像存档和通信系统中,以及开发能够处理多源数据的自动化端到端流程。针对性的临床应用,如早期检测PDAC、改善肾肿瘤分割以及改善肝病风险分层,显示出提高诊断准确性和治疗规划的潜力。伦理考量,如数据隐私、法规遵从性和跨学科合作,对于成功转化为临床实践至关重要。人工智能在腹部影像学中的变革潜力不仅在于辅助放射科医生,还在于通过实现更快、更准确和以患者为中心的医疗来促进精准医学。通过创新和合作克服当前的局限性,对于实现人工智能改善患者预后和重新定义腹部放射学格局的全部潜力至关重要。
Abdom Radiol (NY). 2025-5-26
Therap Adv Gastroenterol. 2025-2-23
BMC Oral Health. 2025-4-18
Front Public Health. 2025-4-2
Cureus. 2024-10-29
Cancers (Basel). 2025-4-30
Mayo Clin Proc Digit Health. 2023-10-27
BMC Med Imaging. 2024-11-6
Nat Commun. 2024-8-15